Publication | Open Access

Safety and immunogenicity of a novel recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in China: preliminary report of a randomised, double-blind, placebo-controlled, phase 1 trial

VaccinationVaccine SafetyVaccine DevelopmentPreliminary ReportImmunologyVaccine TestingVirologyVaccine EfficacyMedicineHealthy Adults